Background Pulmonary fibrosis is an emerging complication of SARS-CoV-2 infection. In
this study, we speculate that patients with COVID-19 and idiopathic pulmonary fibrosis (IPF) …

The outbreak of the coronavirus disease 2019 (COVID-19) pandemic, caused by novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the
COVID-19 disease, is a highly infectious and transmissible viral pathogen that continues to …

Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is responsible for
coronavirus disease of 2019 (COVID‐19) that infected more than 760 million people …

During the last three years, since the emergence of the COVID-19 pandemic, a significant
number of scientific publications have focused on resolving susceptibility to the infection, as …

Introduction Anti-spike monoclonal antibodies (mAbs) were previously authorized for the
prevention and treatment of COVID-19 in immunocompromised patients. However, they are …

This pilot study explores alterations in miRNA profiles among pregnant women and their
neonates upon receiving different doses of COVID-19 vaccines. Blood samples, including …

Introduction One of the stages of reproduction of SARS-CoV-2 is the S-protein glycosylation
to facilitate penetration into target cells. It has been suggested that SARS-CoV-2 is able to …

Grape juices are rich in bioactive compounds; however, for these compounds to exert their
functionality, they must be bioaccessible. Thus, the present study evaluated a simulated …

Arsenic (As), a highly toxic metalloid, which causes environmental lung diseases and affects
millions of people worldwide. Respiratory epithelial cells are essential for maintaining lung …